H.R. 1393 · 118th Congress · House

To amend the Controlled Substances Act to define currently accepted medical use with severe restrictions, and for other purposes.

Active· Referred to the Subcommittee on Health.
Introduced
Mar 7, 23
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

This bill provides for the classification of drugs or other substances that are part of approved breakthrough therapies as schedule II controlled substances under the Controlled Substances Act. (Schedule II controlled substances are substances that have a high potential for abuse but have a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions.)

Action Timeline

5
  1. MAR 17, 2023•Committee

    Referred to the Subcommittee on Health.

  2. MAR 07, 2023•IntroReferral

    Introduced in House

  3. MAR 07, 2023•IntroReferral

    Introduced in House

  4. MAR 07, 2023•IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  5. MAR 07, 2023•IntroReferral

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Committees

3

Health Subcommittee

hsif14

Referred: Mar 17, 2023

Active

Judiciary Committee

hsju00

Referred: Mar 7, 2023

Active

Energy and Commerce Committee

hsif00

Referred: Mar 7, 2023

Active